Enliven Therapeutics, Inc.
ELVN
$18.27
-$1.42-7.21%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 23.82% | 10.76% | 12.43% | 9.72% | 235.14% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 57.10% | -0.37% | 7.02% | 12.54% | 33.02% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -99.46% | -- | -- | -- | -- |
Total Current Assets | 19.53% | 10.57% | 12.34% | 13.15% | 242.30% |
|
|||||
Total Current Assets | 19.53% | 10.57% | 12.34% | 13.15% | 242.30% |
Net Property, Plant & Equipment | -56.87% | -47.67% | -41.06% | -34.19% | -29.95% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 54.17% | 84.42% | 103.94% | 34.55% | 15.51% |
Total Assets | 19.82% | 11.45% | 13.36% | 13.18% | 226.38% |
|
|||||
Total Accounts Payable | 152.26% | -31.75% | -61.91% | -53.46% | -84.53% |
Total Accrued Expenses | -2.01% | 58.88% | 115.07% | 191.10% | 239.66% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -74.40% | -48.63% | -22.70% | 3.72% |
Total Finance Division Other Current Liabilities | -98.03% | -41.30% | 1,271.53% | 1,258.39% | 533.11% |
Total Other Current Liabilities | -98.03% | -41.30% | 1,271.53% | 1,258.39% | 533.11% |
Total Current Liabilities | -38.54% | 40.96% | 141.66% | 128.76% | 166.54% |
|
|||||
Total Current Liabilities | -38.54% | 40.96% | 141.66% | 128.76% | 166.54% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -98.33% | -93.31% | -82.46% |
Total Liabilities | -38.70% | 38.51% | 132.58% | 118.91% | 150.25% |
|
|||||
Common Stock & APIC | 38.24% | 28.08% | 27.65% | 27.24% | 6,527.14% |
Retained Earnings | -57.64% | -63.09% | -72.46% | -81.57% | -86.39% |
Treasury Stock & Other | -60.99% | 264.63% | -25.23% | -- | -- |
Total Common Equity | 26.00% | 10.18% | 9.30% | 9.02% | 420.09% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 26.00% | 10.18% | 9.30% | 9.02% | 420.09% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 26.00% | 10.18% | 9.30% | 9.02% | 237.21% |
|